CTNNB1 and neoplasm: MBWNT tumours formed a single subgroup (n=33) characterised by CTNNB1 mutations, loss of chromosome 6, and an expected favourable prognosis (5-year overall survival: 93% [95% CI 82–100]; figure 1B).